[Weight reduction. Antiobesity drug treatment in type-2 diabetics].
Verspohl
Eugen J
EJ
Institut für Pharmazeutische und Medizinische Chemie Hittorfstr. 58-62, 48149 Münster.
D000818:Animals; D019440:Anti-Obesity Agents / Q000494:pharmacology / Q000627:therapeutic use*; D001067:Appetite Depressants / Q000627:therapeutic use*; D002986:Clinical Trials as Topic; D003503:Cyclobutanes / Q000627:therapeutic use*; D003924:Diabetes Mellitus, Type 2 / Q000150:complications* / Q000628:therapy*; D006801:Humans; D007783:Lactones / Q000494:pharmacology / Q000627:therapeutic use*; D009765:Obesity / Q000150:complications* / Q000188:drug therapy*; D000077403:Orlistat; D015431:Weight Loss
D019440:Anti-Obesity Agents; D001067:Appetite Depressants; D003503:Cyclobutanes; D007783:Lactones; D000077403:Orlistat; C058254:sibutramine
Erschwertes Abnehmen. Adipositas-Behandlung beim Typ-2-Diabetiker.